MY STORY

I was born in South Africa and moved to Australia to study medicine. I graduated from UNSW School of Medicine with Honours and underwent intern and residency years at Royal North Shore Hospital before commencing the formal surgical program in the challenging Southwest Sydney Network. After successfully completing the intense surgical training program through Liverpool, Campbelltown and Tweed Hospitals, I was awarded Fellowship of the Royal Australasian College of Surgeons (FRACS).

I acquired further subspecialty training and experience through coveted fellowship positions on the Breast, Endocrine, Head and Neck Unit at Liverpool Hospital and the Surgical Oncology and Sarcoma Unit at Prince of Wales Hospital and Royal Hospital for Women. Extensive additional coursework has added further expertise, including proficiency in bedside thyroid and parathyroid ultrasound.

I have an academic interest in education and research, particularly in the field of thyroid cancer, which has led to numerous national and international conference presentations and publications. I regularly attend courses and conferences locally and overseas to further my knowledge and keep up to date with the latest research, techniques and guidelines.


I co-chair the Liverpool and Campbelltown Endocrine MDT meeting which is comprised of a panel of experts in Endocrine Surgical conditions, therefore providing my patients with access to additional expert opinions.


I take great pleasure in regularly training and mentoring junior surgeons and medical students, and I am active in teaching as a lecturer for Western Sydney University. Away from work, I enjoy spending time with my wife and 3 daughters. 

I have performed thousands of endocrine, head and neck, general, laparoscopic and oncological operations with a strong track record of excellent patient outcomes and satisfaction. My mission is to provide experienced, individualised and expert surgical care for conditions affecting the thyroid, parathyroids, neck, breasts, salivary glands, adrenals, soft tissue tumours, herniae, gall bladder and other conditions as listed under 'my services'. 

My passion is complete and holistic care focused on your needs, and I ensure that every patient understands all aspects of their condition, options and recommendations for treatment.

 

RESEARCH

 

PUBLICATIONS

  1. Sacral nerve stimulation for faecal incontinence: medium-term follow-up from a single institution. Patton V., Abraham E., Lubowski, DZ, ANZ Journal of Surgery. (2016).

  2. Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence. Abraham E, Roshan D, Tran B, Graham S, Lehane C, Wykes J, Campbell P, Ebrahimi A. ANZ Journal of Surgery (2017)

  3. Microscopic positive margins strongly predict reduced disease-free survival in in T4a papillary thyroid cancer. Abraham E., Roshan D., Tran B., Graham S, Lehane C., Wykes J., Campbell P., Ebrahimi A. Presented at the World Congress on Thyroid Cancer, Boston (2017). Top ranked submission award. Head and Neck (2019).

  4. An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma. Tran B, Roshan D, Abraham E, Garibotto N, Wang L, Campbell P, Ebrahimi A. Presented at the World Congress on Thyroid Cancer, Boston (2017), Journal of Clinical Endocrinology and Metabolism (2018).

  5. The Prognostic Impact of Tumor Size in Papillary Thyroid Carcinoma is Modified by Age. Tran B, Roshan D, Abraham E, Garibotto N, Wang L, Campbell P, Wykes J, Ebrahimi A. Thyroid (2018) - ***High impact article***

  6. Response to: 'The relationship between microscopic positive margins in papillary thyroid cancer and disease recurrence.' Abraham et al, ANZ Journal of Surgery (2018).

  7. The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer. Abraham E, Roshan D, Tran B, Wykes J, Campbell P, Ebrahimi A. Journal Surgical Oncology (2019). 

  8. Primary cavernous haemangioma of the thyroid - a rare pathology. Bains H, Agonstino N, Limmer, A, Singh A, Abraham E. ANZ Journal of Surgery (2020)

  9.  Lymphovascular invasion and risk of recurrence in papillary thyroid carcinoma. Wagner K, Abraham E, Roshan D, Tran B, Wykes J, Campbell P, Ebrahimi A. ANZ Journal Surgery (2020). 

BOOK CHAPTER

  1. Goltsman D, Cheong JY, Posner A, Abraham E, Azimi F, Warrier S. The role of negative pressure wound therapy for salvaging implant based reconstruction. Shiffman MA, Low M, Recent clinical techniques, results, and research in wounds, Springer, Berlin 2018  

PRESENTATIONS

  1. Sacral nerve stimulation for faecal incontinence: medium-term follow-up from a single institution. Patton V, Abraham E, Lubowski DZ. RACS ASC, Kuala Lumpur, 2012

  2. Microscopic positive margins in papillary thyroid cancer do not impact disease recurrence. Abraham E, Roshan D, Tran B, Graham S, Lehane C, Wykes J, Campbell P, Ebrahimi A. RACS ASC, Adelaide, 2017

  3. Number of nodal metastases and extranodal extension in papillary thyroid cancer. Roshan D, Abraham E, Tran B, Graham S, Lehane C, Wykes J, Campbell P, Ebrahimi A. RACS ASC, Adelaide 2017

  4. A critical analysis of tumour size in papillary thyroid carcinoma and development of a modified T staging system based on size and extrathyroidal extension. Tran B., Roshan D., Abraham E., Graham S, Lehane C., Wykes J., Campbell P., Ebrahimi A. RACS ASC, Adelaide 2017

  5. A critical analysis of the number of lymph node metastases and extranodal extension in papillary thyroid cancer. Roshan D, Abraham E, Tran B, Graham S, Lehane C, Wykes J, Campbell P, Ebrahimi A. RACS ASC, Adelaide 2017

  6. A critical analysis of the American Joint Committee on Cancer 8th edition revised staging system for well-differentiated thyroid cancer in a cohort of patients with papillary thyroid carcinoma. Ebrahimi A, Roshan D, Abraham E, Tran B, Graham S, Lehane C, Wykes J, Campbell P. RACS ASC, Adelaide 2017

  7. Is lymphovascular invasion an independent prognostic factor for papillary thyroid carcinoma? Bakhtiar A, Roshan D, Abraham E, Tran B, Graham S, Lehane C, Wykes J, Campbell P, Ebrahimi A. RACS ASC Adelaide 2017

  8. Microscopic positive margins strongly predict reduced disease-free survival in in T4a papillary thyroid cancer. Abraham E, Roshan D, Tran B, Graham S, Lehane C, Wykes J, Campbell P, Ebrahimi A. 3rd World Congress on Thyroid Cancer, Boston, USA, 2017. (Selected by World Congress Committee as a Top Rank Presentation)

  9. An analysis of the American Joint Committee on Cancer 8th edition revised T staging system for papillary thyroid carcinoma and exclusion of microscopic extrathyroidal extension. Tran B, Roshan D, Abraham E, Graham S, Lehane C, Wykes J, Campbell P., Ebrahimi A. 3rd World Congress on Thyroid Cancer, Boston, USA, 2017

  10. The prognostic significance of macroscopic extrathyroidal extension into strap muscles versus other structures in papillary thyroid cancer and implications for AJCC staging. Tran B, Roshan D, Abraham E, Graham S, Lehane C, Wykes J, Campbell P., Ebrahimi A. 4th Congress of European ORL-HNS, Barcelona, Spain, 2017

  11. The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer. Abraham E, Roshan D, Tran B, Wykes J, Campbell P, Ebrahimi A. Australia and New Zealand Head and Neck Cancer Society (ANZHNCS) ASM, Brisbane, 2017.

  12. A comparison of staging systems for predicting recurrence in papillary thyroid cancer. Roshan D, Abraham E, Tran B, Graham S, Lehane C, Wykes J, Campbell P, Ebrahimi A. GSA ASM, Canberra, 2017

  13. Minimally invasive surgery in Australia: posterior retroperitoneoscopic adrenalectomy. Abraham E, Tan J, Niles N. International Minimally Invasive Surgery Symposium (IMISS), Mahasarakham, Thailand 2018. International invited speaker

FOR ALL APPOINTMENTS:

P: (02) 4627 6921

F: (02) 4620 6766

E: ENDOCRINE.HEADANDNECK@GMAIL.COM

©2018 BY DR EARL ABRAHAM